In the name of Allah, indefinitely beneficent, boundlessly merciful

Slides:



Advertisements
Similar presentations
JFDA & HAI Workshop Towards equitable and affordable medicine prices policy in Jordan 4-5 December 2007 Strategies to aid market entry and competition.
Advertisements

Biopharmaceutical Quality
Personal Finance Product Labels. Food Products Required Information by the FDA Common name Form of food (whole, chopped, diced, etc) Net weight or volume.
BACKGROUND: The Directorate General of Drug Administration under the Ministry of Health & Family Welfare, Government of the People's Republic of Bangladesh,
Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.
Introduction to Pharmacy Course Teacher: Asim Kumar Bepari.
Introduction to Regulation
Special Topics in IND Regulation
HOW TO REGISTER A NEW FIRM??????? STEPS AND REQUIREMENTS!!!!
Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences,
Drugs and Cosmetics Act, 1940 & Drugs and Cosmetics Rules 1945
ZHRC/HTI Financial Management Training
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
1. RCC Industry Panel – Consumer Products Presentation to RCC Stakeholder Dialogue Session June 20, 2013 Darren Praznik President & CEO, Canadian Cosmetic,
Why Pharmacy? “Indian pharmaceutical Industry is one of the world’s largest and most developed”
The Changing Food Environment The Role and Activities of the U.S. Food and Drug Administration Transatlantic Consumer Dialogue The Changing Food Environment.
Massmart Presentation on Medicines and Related Substances Amendment Bill, 2008 Presentation by Graham Rebello Massmart Channel Executive.
What You Want to Know About Generic Drugs Generic Drugs: Safe. Effective. FDA-Approved.
Regulations Relating to Foodstuffs for Infants and Young Children (Foodstuffs, Cosmetics and Disinfectants Act, 1972) Briefing to the Portfolio Committee.
Regulatory Overview.
Conference: Generic Drugs in Turkey and the EU THE PORTUGUESE MODEL FOR STIMULATING GENERIC COMPETITION IN THE EU June 2, 2005, Ankara, Turkey Rui Santos.
Trade segments, channels and structures for Natural Ingredients for Health Products Session 7 Centre for the Promotion of Imports from developing countries.
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA. Presentation by: Dr. Joseph K. Yano B.Pharm (Nbi) L.L.B (Moi) Legal Officer Pharmacy and Poisons Board Ministry.
INTRODUCTION TO RA.
Health and Consumers Health and Consumers Health and Consumers Health and Consumers Nutrition, Health and the Consumer: An overview of activities in the.
The perspective of the food and drink manufacturing sector Meeting consumer needs Responding to new challenges Dominique TAEYMANS Director Scientific &
Sri Lanka Ministry of Indigenous Medicine.
SALDA Presentation to the Honourable Portfolio Committee on Health National Health Act Amendment Bill B March 2012.
Presented by J F Luterek, Pr.Eng Hahn & Hahn Attorneys
Pharmacovigilance of Nutraceutical Products
Council for Responsible Nutrition FDA Public Meeting on New Dietary Ingredients Annette Dickinson, Ph.D. November 15, 2004.
OVERVIEW OF THE ROLES OF VARIOUS INSTITUTIONS AND REGULATORY FRAMEWORK FOR AFLATOXIN CONTROL IN TANZANIA RAYMOND N. WIGENGE DIRECTOR OF FOOD SAFETY TFDA.
Quality & Safety of Generic Drugs in the World Market World Bank Conference “Good Intentions – Bad Drugs” March 10, 2005 Washington, D.C. Christine Simmon.
GMP- A Regulatory Perspective. Regulatory Perspective in entering Global Pharma Markets.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
1 CHALLENGES IN REGULATION OF TRADITIONAL AND ALTERNATIVE MEDICINES 24 th March, 2010 MOHSW Conference Room Registration of Herbal Drugs.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
PAHO has created a mechanism in order that the countries that do not have aptitude to guarantee generic insurances accede to them in an immediate.
GCP Guidelines for ASU drugs- Issues & Solutions
Harmonised use of accreditation for assessing the competence of various Conformity Assessment Bodies Dr Andreas Steinhorst, EA ERA workshop 13 April 2016,
Veterinary Products Management and Quality Control System in Thailand : Veterinary Vaccine Tasanee Lorchaivej Workshop on the Veterinary Products.
Link between legal framework of VMP regulation and VICH GLs in Japan Takashi Kozasa DVM Ministry of Agriculture, Forestry and Fisheries Government of Japan.
Welcome To Online Health Portal - Medi Tree India
Vitamins, Herbs and Nutritional Supplements Stacyann Moye Kaplan University HW499.
Global Nutraceuticals Industry Analysis till 2017 – Emerging Markets in Asia-Pacific and Latin America to Drive Growth provides a comprehensive analysis.
Course: Pharmacognosy-I Course Instructor: Nishat Jahan.
CHAPTER 8 Global Use of Complementary and Alternative Medicine (CAM) and Treatments.
INTRODUCTION A national drug policy is a document which covers all the areas and issues related to drugs. This document outlines all aspects of drugs.
Pharmacy orientation PPP211 Lec. 2 (Pharmacy Career)
Jordan Food & Drug Administration Administration.
PHARMA HELPLINE SOCIETY we care,we assist, we help Announces on line courses for the overall development of pharmacy professionals and students. These.
The Law of the KR «On making amendments and changes to certain legislative acts of the KR» 4 th MeTA Forum in the Kyrgyz Republic Bishkek, December 8,
RAC Regulatory Affairs Certification
Executive Director, Registrar Corp
Dr. Sekagya Yahaya Hills (MPH , BDS) Traditional Healer
NUTRACEUTICAL FORMULATION TECHNOLOGY HHV 5014
Introduction to the Italian Cosmetic System
Karen Proud, President Consumer Health Products Canada
Over the Counter (OTC) Drugs & Dietary Supplements Market Global Opportunity Analysis and Industry Forecast,
Jordan Food & Drug Administration
MONOJO Biotech Services Centre.
Role of Industry Self-regulation in Phytosanitary Compliance
MONOJO Biotech Services Centre.
Generic Medical Device Company (“MDC”)
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Ch 18: Pharmacy.
A FRIENDLY REMINDER ON OTC DRUGS. DRUG REGULATIONS IN THE PHILIPPINES.
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA
Expert Speak: How Pharma Companies Can Grow Their Business?
Presentation transcript:

In the name of Allah, indefinitely beneficent, boundlessly merciful

Noor Muhammad Mahar B.Pharm, LLB, M.A (International Relations) Media Secretary PPA Consultant – CEO NCI – NOOR CONSULTANT INT. Ex. Regulatory Affairs Manager – Export/Import/Local (Ferozsons, BF Biosciences, Medipak, CCL) Ex. Medico legal Executive – FDA USA

DRAP ACT 2012 Issues and Future Health Challenges

Drug Regulatory Authority Pakistan D R A P   DRAP Act. 2012 Drug Regulatory Authority Pakistan 12 November 2012 President signs Drug Regulatory Authority Bill

  DRAP Act. 2012 PRELIMINARY This Act may be called the Drug Regulatory Authority of Pakistan Act, 2012. Definitions “Act” means the Drugs Act, 1976 (XXXI of 1976). “Alternative Medicine” means a product used exclusively in Homeopathic, Unani, Ayurvedic, Biochemic, Chinese or other traditional system of treatment.

DRUG REGULATORY AUTHORITY PAKISTAN Composition of authority - 13 Directors Director Pharmaceutical Evaluations & Registration. Director Drug Licensing Director Quality Assurance & Laboratory testing Director medical devices and medical cosmetics Director Biological Drugs Director Controlled drugs Director Pharmacy Services Director Health & OTC Products Director Costing & Pricing Director Budget & Accounts Director Administration, Human Resource & Logistics. Director Legal Affairs Director Management of Information Services

The General Director, Administration & Monitoring   DRAP Act. 2012 D R A P POLICY BOARD The General Director, Administration & Monitoring (Members) National Regulations And Services Division (NRSD) Chairperson CEO Member Representative of ministry of law & justice Member Secretary of concerned Department Govt of Balochistan Member Secretary of concerned Department Govt of Sindh Member Secretary of concerned Department Govt of KPK Member Secretary of concerned Department Govt of Punjab Member Secretary of concerned Department Govt of Gilgit Baltistan Member Representative of Federally Administered Tribal Area Member Six experts from Public & Private Sector with equal representation from each province, these members from different specialties, Members

Drug Regulatory Authority Pakistan Aims & objectives To prevent the sale of fake, substandard & non registered medicines/ Therapeutics Stop hoarding, To provide a competitive a edge in advance manufacturing technologies like USA, Canada To focus on ISO, cGMP, GLP, GSP etc. To improve the Export standards to create foreign exchange opportunities. To compete the Global market with the theme “ MADE IN PAKISTAN”. To bring harmony in manufacturing, storage, distribution, sales, exports, imports of medicines/ Nutraceuticals/herbal remedies/Unani/Ayuvedic. Develop ethical criteria for drug promotion, marketing , advertising . Registration of herbal medicines to acknowledge, recognize & legalize the role of alternative medicines in modern era. To improve manufacturing standards, scope, worth & Status of pharma related industry To build the confidence of patients, Doctor, Hakeem and allied departments. To develop healthy competition on quality, efficacy & affordability. To build & establish the trust on alternative medicine through global standards. To provide customer friendly environment for all segments of Pharma manufacturing industry.                                                                                    

DRAP, Nutraceuticals /Herbal SRO 412 & FUTURE OF DRAP PHARMACIST AS Technical/QUALIFIED PERSON INDUSTERIAL GROWTH & NEXT FEW YEARS … PHARMACIST ROLE IN NUTRACEUTICALS TESTING LAB Role of Pharmacy Dept. & future Study planning

DRAP Act. 2012 "Alternative Medicine" "Alternative Medicine" means medicinal products which include, indigenous or Unani medicine, imported medicinal product, Homeopathic medicines ,new medicines with“therapeutic claim” herbal preparation, herbal substance ,proprietary medicines, herbal medicinal product , Phytomedicines or any other product meant for therapeutic or preventive use which have been derived from plant, animal or mineral ingredients alone or their combinations but does not contain chemically defined synthetic ingredients; “therapeutic claim” Nutraceuticals/Food Supplement, “pro-biotics”

Health and OTC Products. a. Food supplements (Neutraceuticals or dietary or health supplements). b. Nutritional supplements, pro-biotics c. Baby Milks and Foods (infant or baby formulae, follow up formulae, formulae for special medical purposes or complementary foods intended for infants and young children). d. Disinfectants. e. Medicated cosmetics, and shampoos containing natural ingredients. f. Medicated Soaps containing natural ingredients g. Tooth pastes/mouthwashes/throat lozenges/gargles containing natural ingredients. h. Medicated cosmetics/Derma-care products/Balms/ patches/ medicated oils natural ingredients i. Any other.

Enlistment of OTC & Health Products. Documents? 1. Product Profile Master Formula. 3. Manufacturing process and in-process controls 3. Testing specifications for raw material and finished products. 4. Shelf life and storage.(shelf life shall base on stability data). 5. Recommended Conditions for use / disease reduction claims as per standards of evidence. 6. Packaging and labeling information. 7. Maximum Retail price. 8. Fee deposit receipt. 9. undertaking

Challenges for Authorized Person “PHARMACIST” a. Food supplements (Neutraceuticals or dietary or health supplements). b. Nutritional supplements, pro-biotics and pre-biotics c. Baby Milks and Foods (infant or baby formulae, follow up formulae, formulae for special medical purposes or complementary foods intended for infants and young children). d. Disinfectants. e. Medicated cosmetics, and shampoos containing natural ingredients. f. Medicated Soaps containing natural ingredients g. Tooth pastes/mouthwashes/throat lozenges/gargles containing natural ingredients. h. Medicated cosmetics/Derma-care products/Balms/ patches/ medicated oils natural ingredients i. Any other.

SRO 412 “Top Challenges of alternative products business PHARMACIST” Industrial management “Contract Acceptor” means a manufacturer who manufacturers the finished product under the label and brand of contract giver. “Contract Giver” means the person who awards the contract of particular products under his brand . Business Scope & SRO 412 Business competition Documentation – LAYOUT- Production FLOW & managment Export & import – market & new challenges

S.R.O. 412 Pharmacist Future DRAP & technical staff Name, along with appointment letter, address, qualification and experience of the technical staff responsible for manufacturer and testing. The qualification and experience should be backed up with attested proof.

EMERGENCE OF NUTRACEUTICALS Higher Confidence in Product Quality and Effectiveness Improved Market for Nutraceutical Products Increased Public Awareness Increased Healthcare Industry Awareness

Nutraceuticals world come back to nature………

Nutraceutical Int. International status & scope INDIA USA & other country

Nutraceutical increase life exceptancy

Bourne Partners released an April 2013 Nutraceutical Sector Report that put the global nutraceutical market at $142 billion in 2011. With an estimated growth rate of 6.4% (CAGR), the market is expected to reach $204.8 billion by 2017. More than 60% of Americans use alternative medical therapies, nutraceuticals (herbals/botanicals) account for a significant proportion. 

REQUIREMENT OF REGULATION FOR NUTRACEUTICAL PRODUCTS Confusion regarding the original use, potency and safety of the product. Need for a uniform nomenclature for this booming Nutraceutical market across the globe. Requirement of careful formulation in a hygienic environment.

A REVIEW OF RULE AND REGULATION IN MODERN WORLD COUNTRY LEGAL BODY United States Food and Drug Administration (FDA)  according to the Dietary Supplement, Health and Education Act (DSHEA) of 1994 European Union European Food Safety Authority (EFSA) according to Directive 2002/46/EC of the European Parliament and Council of 2002 Canada Natural Health Products as per The Natural Health Product Regulations 2004 Japan Foods for Specified Health Use (FOSHU) established in 1991 Australia  Therapeutics Goods Act, 1989 Russia Concerning the Procedure for the Examination and Health Certification of Active Dietary Supplements 1997  Biologically Active Dietary Supplements (BADS)

“LET FOOD BE YOUR MEDICINE” Greek physician HIPPOCRATES (known as father of medicines) said: “LET FOOD BE YOUR MEDICINE”